Jubilant Life arm inks pact to acquire Inipharm Inc for around $28.5 mn

The company#39;s wholly-owned subsidiary has entered into a stock purchase agreement to acquire 534,194 shares of common stock of biotechnology firm Inipharm Inc USA, for a cash consideration of USD 534.20 per share, Jubilant Life Sciences said in a filing to BSE.

from Moneycontrol Business News https://ift.tt/2RlKEoZ